Dr. Vincent Éthier CML Chronic Myeloid Leukemia
VIDEOS
ARTICLES
Canadian real-world experience of Asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
August 2023, Leukemia Research
S159 Québec CML Research group analysis of treatment in chronic myelogenous leukemia: switching is driven by intolerance and similar across tyrosine kinase inhibitors and lines of treatment
June 2022, HemaSphere
Canadian real-world experience of Asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
August 2023, Leukemia Research
S159 Québec CML Research group analysis of treatment in chronic myelogenous leukemia: switching is driven by intolerance and similar across tyrosine kinase inhibitors and lines of treatment
June 2022, HemaSphere
